Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children

Purpose: The novel coronavirus SARS-CoV-2 (COVID-19) and the resultant nationwide lockdown and travel restrictions led to difficulty in providing timely and regular treatment to patients with childhood cancers such as retinoblastoma. This study is aimed at assessing the demography, clinical presenta...

Full description

Bibliographic Details
Main Authors: Rolika Bansal, Ankita Aishwarya, Raksha Rao, Marem C Christy, Mrittika Sen, Harika Regani, Poonam Bagai, Vijay A Reddy, Kaustubh Mulay, Pramila Bongoni, Santosh G Honavar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=10;spage=2617;epage=2624;aulast=Bansal
_version_ 1818588275117391872
author Rolika Bansal
Ankita Aishwarya
Raksha Rao
Marem C Christy
Mrittika Sen
Harika Regani
Poonam Bagai
Vijay A Reddy
Kaustubh Mulay
Pramila Bongoni
Santosh G Honavar
author_facet Rolika Bansal
Ankita Aishwarya
Raksha Rao
Marem C Christy
Mrittika Sen
Harika Regani
Poonam Bagai
Vijay A Reddy
Kaustubh Mulay
Pramila Bongoni
Santosh G Honavar
author_sort Rolika Bansal
collection DOAJ
description Purpose: The novel coronavirus SARS-CoV-2 (COVID-19) and the resultant nationwide lockdown and travel restrictions led to difficulty in providing timely and regular treatment to patients with childhood cancers such as retinoblastoma. This study is aimed at assessing the demography, clinical presentation, treatment strategies, and outcome of treatment defaulters due to the lockdown. Methods: Cross-sectional, observational study of retinoblastoma patients at a tertiary care ocular oncology center during the first wave of COVID-19 and the resulting nationwide lockdown. Results: Of the 476 eyes of 326 patients undergoing active management with a median age of 57 months (range: 4–214 months), 205 (63%) patients returned for follow-up after a mean delay of 45.8 ± 24.3 weeks (range: 8–80 weeks) and 121 (37%) were defaulters according to the data analyzed till June 30, 2021. Distance of residence was ≥1000 km for 148 patients (46%). In terms of need for active treatment, the number of emergent cases was 2 (<1%), 11 (3%) were urgent, and 313 (96%) were semi-urgent. International classification groups D (n = 107 eyes, 23%) and E (n = 173 eyes, 36%) were in majority, and 13 eyes (4%) and 4 eyes (1%) were at stages 3 and 4, respectively. Prior to lockdown, 86 eyes (18%) had active tumor, which remained unchanged (n = 26, 30%) or worsened (n = 49, 60%) after failure to follow-up. Vision (47%), eye (92%), and life salvage (98%) were achieved by individualized protocol-based management after the patients returned for further management. Five children succumbed to intracranial extension. Conclusion: The COVID-19-related nationwide lockdown has deprived retinoblastoma patients of optimal and timely management, leading to prolonged treatment interruptions, delays, permanent default, and death. It is of paramount importance for all the stakeholders to increase awareness, make necessary travel and logistic arrangements, and ensure continuity of care for children with retinoblastoma.
first_indexed 2024-12-16T09:22:10Z
format Article
id doaj.art-8dcc8a69b9a14d2b90ad0a91a0118c9b
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-16T09:22:10Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-8dcc8a69b9a14d2b90ad0a91a0118c9b2022-12-21T22:36:44ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892021-01-0169102617262410.4103/ijo.IJO_2243_21Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 childrenRolika BansalAnkita AishwaryaRaksha RaoMarem C ChristyMrittika SenHarika ReganiPoonam BagaiVijay A ReddyKaustubh MulayPramila BongoniSantosh G HonavarPurpose: The novel coronavirus SARS-CoV-2 (COVID-19) and the resultant nationwide lockdown and travel restrictions led to difficulty in providing timely and regular treatment to patients with childhood cancers such as retinoblastoma. This study is aimed at assessing the demography, clinical presentation, treatment strategies, and outcome of treatment defaulters due to the lockdown. Methods: Cross-sectional, observational study of retinoblastoma patients at a tertiary care ocular oncology center during the first wave of COVID-19 and the resulting nationwide lockdown. Results: Of the 476 eyes of 326 patients undergoing active management with a median age of 57 months (range: 4–214 months), 205 (63%) patients returned for follow-up after a mean delay of 45.8 ± 24.3 weeks (range: 8–80 weeks) and 121 (37%) were defaulters according to the data analyzed till June 30, 2021. Distance of residence was ≥1000 km for 148 patients (46%). In terms of need for active treatment, the number of emergent cases was 2 (<1%), 11 (3%) were urgent, and 313 (96%) were semi-urgent. International classification groups D (n = 107 eyes, 23%) and E (n = 173 eyes, 36%) were in majority, and 13 eyes (4%) and 4 eyes (1%) were at stages 3 and 4, respectively. Prior to lockdown, 86 eyes (18%) had active tumor, which remained unchanged (n = 26, 30%) or worsened (n = 49, 60%) after failure to follow-up. Vision (47%), eye (92%), and life salvage (98%) were achieved by individualized protocol-based management after the patients returned for further management. Five children succumbed to intracranial extension. Conclusion: The COVID-19-related nationwide lockdown has deprived retinoblastoma patients of optimal and timely management, leading to prolonged treatment interruptions, delays, permanent default, and death. It is of paramount importance for all the stakeholders to increase awareness, make necessary travel and logistic arrangements, and ensure continuity of care for children with retinoblastoma.http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=10;spage=2617;epage=2624;aulast=Bansalcovid-19ocular oncologyretinoblastomasars-cov-2treatment delay
spellingShingle Rolika Bansal
Ankita Aishwarya
Raksha Rao
Marem C Christy
Mrittika Sen
Harika Regani
Poonam Bagai
Vijay A Reddy
Kaustubh Mulay
Pramila Bongoni
Santosh G Honavar
Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children
Indian Journal of Ophthalmology
covid-19
ocular oncology
retinoblastoma
sars-cov-2
treatment delay
title Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children
title_full Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children
title_fullStr Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children
title_full_unstemmed Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children
title_short Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children
title_sort impact of covid 19 nationwide lockdown on retinoblastoma treatment and outcome a study of 476 eyes of 326 children
topic covid-19
ocular oncology
retinoblastoma
sars-cov-2
treatment delay
url http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=10;spage=2617;epage=2624;aulast=Bansal
work_keys_str_mv AT rolikabansal impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT ankitaaishwarya impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT raksharao impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT maremcchristy impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT mrittikasen impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT harikaregani impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT poonambagai impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT vijayareddy impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT kaustubhmulay impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT pramilabongoni impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children
AT santoshghonavar impactofcovid19nationwidelockdownonretinoblastomatreatmentandoutcomeastudyof476eyesof326children